公司名稱: 金朝陽集團有限公司 呈交日期: 2025年12月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00878 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | 本月底法定/註冊股本總額： HKD 500,000,000 股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年11月30日 狀態 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 呈交日期: 2025年11月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00878 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | 本月底法定/註冊股本總額： HKD 500,000,000 FF301 第 1 ...

Core Viewpoint - Weikang Pharmaceutical reported a significant decline in revenue and net profit for the first three quarters of 2025, attributing the drop primarily to a reduction in the scope of consolidation [1][2]. Financial Performance - The company achieved a revenue of 151.32 million yuan, a year-on-year decrease of 59.2% [2]. - The net profit attributable to shareholders was -123.85 million yuan, reflecting a staggering year-on-year decline of 380.87% [1][2]. - The basic and diluted earnings per share were both -0.8554 yuan, down 380.83% compared to the previous year [2]. - The weighted average return on net assets was -11.40%, a decrease of 14.64% year-on-year [2]. Operational Insights - Weikang Pharmaceutical has faced consecutive losses in 2023 and 2024, with losses of 8.95 million yuan and 147 million yuan, respectively [2]. - The company is a national high-tech enterprise engaged in pharmaceutical research, production, and sales [3]. Project Delays - The "Marketing Network Center Construction Project" has experienced multiple delays, with the completion date extended from June 30, 2025, to June 30, 2026 [4][5]. - The cumulative investment in this project as of June 30, 2025, was 8.93 million yuan, with an investment progress of 41.68% [5]. Market Performance - As of October 29, the stock price of Weikang Pharmaceutical was 23.47 yuan per share, with a total market capitalization of 3.398 billion yuan [6]. - The stock has seen a price increase of 57.20% since the beginning of 2025 [6].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 金朝陽集團有限公司 呈交日期: 2025年10月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00878 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | 本月底法定/註冊股本 ...

SOUNDWILL HOLDINGS LIMITED 金朝陽集團有限公司 * (Incorporated in Bermuda with limited liability) （於百慕達註冊成立之有限公司） (Stock Code: 878) （股份代號：878） NOTIFICATION LETTER 通知信函 16 September 2025 Dear Non-registered Holder(s) (Note 1) , SOUNDWILL HOLDINGS LIMITED (the "Company") — Notification of publication of Interim Report 2025 (the "Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communications are available on the Company's website at (www.soundwill.com.hk) and the web ...

SOUNDWILL HOLDINGS LIMITED NOTIFICATION LETTER 通知信函 16 September 2025 Dear Registered Shareholders, SOUNDWILL HOLDINGS LIMITED (the "Company") — Notice of publication of Interim Report 2025 (the "Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communications are now available on the Company's website at (www.soundwill.com.hk) and the website of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") at (www.hkexnews.hk) respectively (the "Website ...

Financial Performance - Total revenue for the six months ended June 30, 2025, was HKD 180.7 million, a decrease from HKD 1,030.1 million in the same period of 2024[8]. - The net loss attributable to shareholders for the period was HKD 1,337.6 million, compared to a loss of HKD 974.8 million in the previous year, representing a year-on-year increase of approximately 37.2%[8]. - Basic loss per share for the six months was HKD 4.72, compared to HKD 3.44 in the same period of 2024[8]. - The company reported a total comprehensive loss of HKD 1,331,336,000, which includes a loss of HKD 1,337,584,000[77]. - The company reported a pre-tax loss of HKD 1,322,996,000 for the six months ended June 30, 2025, compared to a loss of HKD 916,737,000 in the previous year[99]. - The net loss for the six months ended June 30, 2025, was HKD 1,337,584,000, compared to a net loss of HKD 974,549,000 for the same period in 2024, representing a 37.2% increase in losses[67]. Assets and Liabilities - Total assets as of June 30, 2025, were HKD 16,617 million, down from HKD 17,975 million as of December 31, 2024[8]. - The net asset value decreased to HKD 14,345 million from HKD 15,677 million in the previous year[8]. - Total liabilities decreased from HKD 1,669,611,000 to HKD 1,202,564,000, a reduction of 28.0%[74]. - The total liabilities as of June 30, 2025, were HKD 2,271,780,000, compared to HKD 2,298,398,000 as of December 31, 2024[94]. - The company's equity attributable to owners as of June 30, 2025, was HKD 14,345,405,000, down from HKD 15,676,741,000 at the beginning of the year[77]. Revenue Breakdown - Rental income from property leasing was approximately HKD 162.19 million, accounting for about 90% of total revenue[16]. - Property development revenue for the six months ended June 30, 2025, was approximately HKD 6,833,000, accounting for about 4% of total group revenue[20]. - Property management revenue for the six months ended June 30, 2025, was approximately HKD 11,689,000, representing about 6% of total group revenue[23]. - The company reported other income totaling HKD 31,965,000 for the six months ended June 30, 2025, compared to HKD 34,553,000 in the same period of 2024[95]. Market Conditions and Strategy - The group plans to optimize its tenant mix and enhance property management to adapt to changing consumer trends[14]. - The group will adopt a cautious approach towards land reserve replenishment and property acquisitions in response to the current market conditions[14]. - The overall economic outlook for the second half of 2025 remains cautious, with challenges in consumer sentiment and real estate market confidence[29]. - The real estate market in mainland China is showing signs of stabilization, with first-tier cities recovering faster than third and fourth-tier cities[22]. Cash Flow and Financing - The company's net cash inflow from operating activities for the six months ended June 30, 2025, was HKD 81,580,000, a decrease of 76.4% compared to HKD 345,435,000 for the same period in 2024[80]. - The company experienced a net cash outflow from investing activities of HKD 143,473,000 for the six months ended June 30, 2025, compared to a net inflow of HKD 461,432,000 in the previous year[80]. - The total interest expense for the six months ended June 30, 2025, was approximately HKD 24,819,000, down from HKD 38,576,000 for the same period in 2024[32]. - The group’s cash balance in mainland China is approximately HKD 26,414,000 as of June 30, 2025, down from HKD 110,643,000 as of December 31, 2024[116]. Corporate Governance and Compliance - The company has adopted the corporate governance code and confirmed compliance by all directors for the six-month period[60]. - The audit committee reviewed the interim financial statements and found no disagreements with management[62]. - The group has maintained its listing status on the stock exchange despite a proposal for privatization that was not approved by shareholders[36]. Employee Compensation - The total employee compensation for the six months ended June 30, 2025, was approximately HKD 70,285,000, compared to HKD 73,911,000 for the same period in 2024[41]. - The company incurred employee compensation expenses of HKD 70,285,000, slightly lower than HKD 73,911,000 in the previous year[100]. Environmental and Community Engagement - The group actively participates in community service and has received recognition for its environmental protection efforts, including the "Outstanding Environmental Partner" award[29]. - The group is preparing to establish a dedicated team to address climate change, focusing on carbon reduction and energy-saving projects[28].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年8月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 金朝陽集團有限公司 呈交日期: 2025年9月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00878 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 5,000,000,000 | HKD | | 0.1 | HKD | | 500,000,000 | 本月底法定/註冊股本總 ...

Core Viewpoint - Jin Chao Yang Group (00878) reported a significant decline in revenue and an increase in losses for the first half of 2025, primarily due to reduced income from property development projects and valuation losses on investment properties [1] Financial Performance - Revenue for the first half of 2025 was approximately HKD 181 million, representing a year-on-year decrease of 82.46% [1] - The loss attributable to shareholders was about HKD 1.338 billion, an increase of 37.21% compared to the previous year [1] - The loss per share was HKD 4.72 [1] Reasons for Performance - The decrease in revenue was mainly attributed to reduced income from property development projects [1] - The increase in losses was due to a decline in income from property development and a valuation loss on investment properties amounting to HKD 1.423 billion, compared to a loss of HKD 1.324 billion in the same period of 2024 [1]

格隆汇8月21日丨金朝阳集团(00878.HK)公告，截至2025年6月30日止6个月，集团录得收益约港币1.8亿 元，较去年同期减少约港币8.49亿元。公司拥有人应占亏损约为港币13.38亿元(2024年6月30日：亏损港 币9.748亿元)，较2024年同期亏损增加37%。亏损增加主要由于截至2025年6月30日录得物业发展项目收 入减少及投资物业估值亏损港币14.2亿元，2024年同期则录得亏损港币13.2亿元。公司每股基本亏损为 港币4.72元，而去年同期每股亏损则为港币3.44元。 收益减少主要由于物业发展项目录得的收入减少。 ...